Caplin Point Laboratories Ltd. (CAPLIPOINT): Caplin Point Laboratories Share Price Rises 5.30% Today
- September 1, 2026
- Posted by: Harsh Piplani
- Category: News
Caplin Point Laboratories Ltd. rose to Rs 2,650.65, up 5.30% today, with market capitalisation at Rs 19,125.30 crore.
Caplin Point Laboratories Share Price is at Rs 2,650.65 today, up Rs 133.40 or 5.30% from the previous close of Rs 2,517.25. The stock opened at Rs 2,532.25, hit a high of Rs 2,656.85, touched a low of Rs 2,521.40 and traded with turnover of Rs 1.83 crore. The move keeps the stock in focus within Healthcare and the Pharmaceuticals & Drugs industry.
Caplin Point Laboratories Share Price is drawing attention because the price gain is visible, but the supplied data does not confirm a company-specific trigger. That means today’s move is best read through price action, valuation, profitability, industry benchmarks and peer comparison rather than through any unverified catalyst narrative.
Caplin Point Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,650.65 |
| Previous Close | Rs 2,517.25 |
| Today's Move | Rs 133.4 (+5.3%) |
| Open | Rs 2,532.25 |
| High | Rs 2,656.85 |
| Low | Rs 2,521.4 |
| Turnover | Rs 1.83 crore |
| Market Capitalisation | Rs 19,125.3 crore |
| Market Cap Category | Mid Cap |
Caplin Point Laboratories Ltd. (CAPLIPOINT) rose to Rs 2,650.65 from the previous close of Rs 2,517.25, a move of Rs 133.4 or 5.3%. The stock opened at Rs 2,532.25, reached a high of Rs 2,656.85, recorded a low of Rs 2,521.4.
Caplin Point Laboratories Share Price rose from Rs 2,517.25 to Rs 2,650.65, a gain of Rs 133.4 or 5.3%. The session range of Rs 2,521.4 to Rs 2,656.85 shows the stock spent the day in positive territory after opening at Rs 2,532.25. Because the current price remained close to the intraday high, the session reflected firm buying interest rather than a move that faded sharply into the close snapshot supplied here.
The market capitalisation stood at Rs 19,125.3 crore. The earlier article classified this as Mid Cap, and that size context matters because it places the company well above the broader same-industry median market capitalisation of Rs 683.05 crore and above the same-industry average of Rs 14,252.9 crore. Even without a confirmed event-specific reason, the combination of a 5.30% daily rise and a meaningful industry position is enough to place the stock on active watchlists.
Caplin Point Laboratories Ltd. (CAPLIPOINT) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 19,125.3 crore |
| P/E Ratio | 28.76x |
| P/B Ratio | 5.08x |
| ROE | 21.72% |
| ROCE | 26.22% |
| EPS | Rs 87.53 |
| Book Value Per Share | Rs 495.39 |
| Dividend Yield | 0.16% |
Caplin Point Laboratories Ltd. (CAPLIPOINT) fundamental metrics show P/E 28.76x, P/B 5.08x, ROE 21.72%, ROCE 26.22%. These figures provide context only and are not a buy or sell signal.
Caplin Point Laboratories Ltd. has a market capitalisation of Rs 19125.3 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 28.76x, P/B at 5.08x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.72% and ROCE of 26.22%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 87.53, book value per share of Rs 495.39, dividend yield of 0.16%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.92x, median ROE of 11.81%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 28.76x |
| Benchmark Median P/E | 30.92x |
| Benchmark Average P/E | 48.02x |
| Benchmark P/E Range | 3.87x to 667.16x |
| Company P/B Ratio | 5.08x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 21.72% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 26.22% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 19,125.3 crore |
| Benchmark Median Market Cap | Rs 683.05 crore |
Caplin Point Laboratories Ltd. (CAPLIPOINT) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 28.76x, which is below the benchmark median of 30.92x, a difference of -6.99%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROE of 21.72%, which is above the benchmark median of 11.81%, a difference of +83.91%. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROCE of 26.22%, which is above the benchmark median of 13.65%, a difference of +92.09%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,60,696.31 | 38.8 | 5.43 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,46,062.83 | 83.91 | 13.89 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,91,515.22 | 86.82 | 21.1 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,18,403.7 | 25.69 | 4.3 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,554.33 | 33.94 | 3.25 | 11.83 | 16 |
Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 28.76x compared with the displayed peer median of 38.8x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.72% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 26.22% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a market capitalisation of Rs 19,125.3 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Caplin Point Laboratories Ltd.
- The stock rose 5.30% to Rs 2,650.65 and stayed near the day high of Rs 2,656.85.
- Turnover was Rs 1.83 crore, with price action ranging from Rs 2,521.4 to Rs 2,656.85.
- P/E of 28.76x is below the same-industry median of 30.92x.
- ROE of 21.72% and ROCE of 26.22% are well above industry medians of 11.81% and 13.65%.
- The supplied data confirms a price rise, but not a company-specific catalyst.
About Caplin Point Laboratories Ltd.
Caplin Point Laboratories Ltd. operates in Healthcare and is classified under Pharmaceuticals & Drugs. Based on the supplied comparison set, it sits in an industry that includes very large listed peers such as Sun Pharma, Divi’s, Torrent, Zydus and Cipla. The stock therefore attracts interest not just for short-term movement, but also for how its valuation and returns stack up against better-known pharmaceutical businesses.
Caplin Point Laboratories Share Price is especially notable today because the company combines sub-industry-median P/E with above-industry-median ROE and ROCE. That does not make the stock automatically attractive or unattractive, but it does explain why the name stands out in a same-day scan of price movers.
Track Caplin Point Laboratories Share Price on Univest
Use Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Caplin Point Laboratories Share Price on the Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page. Univest users can also explore the top gainers screener and market blogs for broader market context, peer checks and daily stock analysis.
For active tracking, investors typically watch live price changes, market capitalisation, valuation ratios, sector context and peer metrics in one place. That is especially useful after a session like today, when Caplin Point Laboratories Share Price moved sharply higher but the data set did not assign a confirmed trigger.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Caplin Point Laboratories Share Price rising today?
Ans. Caplin Point Laboratories Share Price rose 5.30% to Rs 2,650.65 from Rs 2,517.25, but the supplied data does not identify a company-specific catalyst behind the move. The previous close was Rs 2,517.25.
What is Caplin Point Laboratories Share Price Today?
Ans. Caplin Point Laboratories Share Price Today is Rs 2,650.65. The stock opened at Rs 2,532.25, hit Rs 2,656.85, touched Rs 2,521.40 and gained Rs 133.40 in the session. The previous close was Rs 2,517.25.
How does the company compare on valuation and profitability?
Ans. The company trades at P/E 28.76x and P/B 5.08x, with ROE 21.72%, ROCE 26.22%, EPS Rs 87.53, book value Rs 495.39 and dividend yield 0.16%. Versus the same-industry benchmark, P/E is below the median 30.92x, while ROE and ROCE are.
How does it compare with major pharma peers?
Ans. It has a smaller market cap than Sun Pharma, Divi's, Torrent, Zydus and Cipla, but its return ratios are competitive. ROCE of 26.22% is above all 5 displayed peers, while ROE of 21.72% is above Sun Pharma, Divi's, Zydus and.
